Patients suffering from inflammatory bowel diseases (IBD), such as Ulcerative Colitis (UC) and Crohn's disease (CD), can develop dysplasia which is a precancerous lesion of the colon or the rectum. Dysplasia can itself progress and transform into neoplasia and lead to colorectal cancer. In IBD, dysplasia can develop on areas that are or have been affected by chronic inflammation; in this setting, the dysplasia is termed Dysplasia Associated to Inflammation (DAI) (figure 1). Dysplasia may also develop independently of chronic inflammation and is termed Sporadic Dysplasia (DSp). Anatomopathological diagnosis of DAI in IBD patients remains difficult, especially when tissue inflammation is present, as regenerative remodeling in the mucosae is observed and impairs dysplasia confirmation. ▲ Figure 1: SCENIC international consensus for classification of dysplasia in the context of IBD (Laine L. et al, Gastroenterology 2015). (A) polypoid pedunculated lesion, (B) polypoid sessile lesion, (C) nonpolypoid superficial elevatedlesion, (D) nonpolypoid flatlesionand (E) nonpolypoid depressedlesion.
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Results
SLC12A2 in literature:
The protein is also called Na-K-2Cl co-transporter 1 (NKCC1) due to its function as transporter of 1 Na + , 1 K + and 2 Clinto the cell. It is involved in ionic balance and cell volume regulation [1] and is influenced by physical, hormonal, signaling and cytokines factors. It is implicated in T cells migration via WNK1-OXSR1/STK39-SLC12A2. [2] In cancer : it is 3 times more abundant in colorectal cancer than in normal tissue. [3] In lung adenocarcinoma, its increase is correlated to more advance and aggressive lesions. [4] In gastric adenocarcinoma, its is associated with poor tumor differentiation. [5] In human glioma cells, its inhibition induces reduction of migration and invasion. [6] Immunohistochemistry for SLC12A2 distribution in UC patients samples and comparison to proteomic results:
IHC evaluation included 11 UC-DAI paired samples: I (n=9) and/or NL (n=9) tissues. Staining intensity scale used ranges from 0 to 4 (0 = none, 1 = low, 2 = medium, 3 = high and 4 = very high). SLC12A2 was more intense in dysplasia in both IHC and proteomics (figure 3AB). Results show that SLC12A2 staining score is more intense in dysplastic than in inflammatory (crypts: p=0.002, bordering epithelium: p=0.0001) and normal tissues (crypts: p=0.001, bordering epithelium: p<0.0001) (figure 3B). SLC12A2 staining in the DAI tissue allows clear delimitation of the dysplastic region from surrounding inflammatory tissue (see red doted line in figure 3E ). 
Evaluation of SLC12A2 distribution in colonic tissues of the AOM/DSS mouse model:
IHC staining intensity scale ranges from 0 to 4 as in UC patients. Staining intensity score of SLC12A2 was significantly more important in dysplastic lesions (n=52) than in inflammatory (I) (n=30) and in normal (N (PBS)) tissues (n=6). IHC scores were significantly increased in advanced lesions HGD (n=12) and ADC (n=6) compared to LGD (n=39) (figure 5). conclusion Merli A-M 1 , Massot C 2 , Bletard N 3 , Quesada Calvo F 1 , Baiwir D 4 , Mazzucchelli G 5 , Smargiasso N 5 , Servais L 6 , Oury C 6 , De Pauw-Gillet M-C 7 , De Pauw E 5 , COIMBRa MARQUEs C. 8 Colard A 9 , Vijverman A 10 , Delvenne P 3 , Meuwis M-A 1 AND Louis E 1 SLC12A2 could be a potential marker of DAI in UC as being able to identify dysplasia and neoplasia from surrounding tissues with inflammation. SLC12A2 requires proper validation to evaluate its power as a specific IHC marker that could be used to clarify difficult cases diagnosed as "indefinite for dysplasia".
 7 proteins were found more abundant in DAI than in I paired tissues by differential label free proteomics  SLC12A2 was only quantified in the DAI group by proteomics  IHC of SLC12A2 in human UC-DAI paired samples confirmed our proteomic results  In UC, staining of SLC12A2 was significantly more intense in DAI than in I and N paired tissues  In UC, staining of SLC12A2 allowed delimitation of DAI lesion from the surrounding I tissue  SLC12A2 detected by IHC showed an association with dysplasia and neoplasia in CAC mouse model  HGD and LGD tissues showed a significant higher staining of SLC12A2 than LGD lesions of the CAC mouse model 
